Hormone receptor status and the corresponding endocrine treatment have been shown to impact survival of breast cancer patients26; however, information on hormone receptor status and human epidermal growth factor receptor 2 was not available in our registry. This evidence concerns the gene NR4A1 and breast carcinoma.